The emergence of variant Creutzfeld-Jakob disease, following on from the bovine
spongiform encephalopathy (BSE) epidemic, led to concerns about the potential risk of …

Attempts to detect infectivity in the blood of humans and animals affected with transmissible
spongiform encephalopathies (TSEs or prion diseases) have often been inconclusive …

Iatrogenic transmission by blood transfusion has been described in cases of human variant
Creutzfeldt-Jakob disease (vCJD), experimental ovine bovine spongiform encephalopathy …

Transmissible spongiform encephalopathies (TSE s) are untreatable, fatal neurologic
diseases affecting mammals. Human disease forms include sporadic, familial and acquired …

Transfusion transmission of the prion, the agent of variant Creutzfeldt‐Jakob disease
(vCJD), is now established. Subjects infected through food may transmit the disease through …

No transmission through transfusion has been reported for classic Creutzfeldt-Jakob
disease (CJD). Moreover, a series of epidemiological surveillance, case-control, and look …

Various experimental studies have shown infectivity in blood in relation to bovine
spongiform encephalitis (BSE) and variant Creutzfeldt–Jakob disease (vCJD). Human to …

The role of blood in the iatrogenic transmission of transmissible spongiform encephalopathy
(TSE) or prion disease has become an increasing concern since the reports of variant …

New-variant Creutzfeldt-Jakob disease (nvCJD) was first described in the UK in 1996 and is
thought to be related to the consumption of cattle suffering from bovine spongiform …

Summary Variant Creutzfeldt–Jakob disease (vCJD) is a novel acquired human prion
disease resulting from human exposure to the agent causing bovine spongiform …